Mark Heinen - Chief Financial Officer at Better Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
BTTX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Heinen since 10 Jan 2025

Holdings reported by Mark Heinen for Better Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 139,723 $23,739 $0.1699 05 Apr 2023 Direct
Common Stock 2,281 $387 $0.1699 01 Mar 2023 By daughter
Stock Option (Right to Buy) 28,550 01 Mar 2023 Direct Common Stock

Transactions reported by Mark Heinen for Better Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.